'Survival gene' stops strains of tuberculosis mutating into deadly 'superbugs'

January 27, 2017
This photomicrograph reveals Mycobacterium tuberculosis bacteria using acid-fast Ziehl-Neelsen stain; Magnified 1000 X. The acid-fast stains depend on the ability of mycobacteria to retain dye when treated with mineral acid or an acid-alcohol solution such as the Ziehl-Neelsen, or the Kinyoun stains that are carbolfuchsin methods specific for M. tuberculosis. Credit: public domain

Scientists have discovered a key 'survival gene' that prevents strains of tuberculosis (TB) from mutating into drug-resistant 'superbugs'.

In a joint study, published today, Friday January 27th 2017, in the journal Nature Communications, scientists from the Centro Nacional de Biotecnología in Madrid and the University of Sussex in Brighton, report the discovery of a gene called NucS that dramatically reduces mutation rates in mycobacteria—the infectious microbe which causes tuberculosis (TB).

TB, which is spread from person to person through the air, is one of the top 10 causes of death worldwide with 1.8 million people dying from the disease last year. Drug-resistant strains of TB have already been identified in 105 countries and the researchers involved in this study believe that the identification of a key gene, required to supress mutation rates in mycobacteria, is an important step towards understanding how 'superbugs' develop.

Using a genetic screen, which involved individually knocking out nearly every gene (11,000 ) in mycobacteria, and screening whether mutant strains grew on a specific antibiotic (rifampicin), the scientists discovered that a DNA repair enzyme, produced by the NucS gene, dramatically reduces mutations from occurring.

The researchers also discovered that genetic variations in the NucS gene significantly influence the mutation rates in clinically isolated strains of mycobacteria. More work needs to be done, but the scientists believe this discovery could also play a role in understanding the development of in patients already suffering from TB.

Professor Aidan Doherty, from the University of Sussex, said: "The rise of antibiotic resistance is a major threat to global health and, if we are to limit its impact on infectious diseases, we first need to identify the mechanisms that prevent bacteria from mutating in the first place. This knowledge will then enable us to better understand how pathogens develop into 'superbugs'.

"Incredibly, for many years it was believed that mycobacteria lacked any mutation avoidance genes. Therefore, the discovery that the NucS gene reduces the rate at which mutations occur in these pathogens is a crucial first step towards identifying the genetic factors that influence the onset of antibiotic-resistance. This will enable scientists and clinicians to screen for strains that are most likely to develop drug-resistance and figure out strategies to tackle this serious threat."

Professor Jesus Blázquez, from the Centro Nacional de Biotecnología, said: "Not only does this study identify that mutations can be reversed in mycobacteria, it reveals that the loss of this DNA repair process can cause a huge increase in the mutation rates, significantly increasing the likelihood of these pathogens acquiring mutations - which can cause antibiotic resistance.

"Now we know that that NucS dramatically reduces in —it is vital that we take advantage of this and work towards exploiting this discovery to help doctors and microbiologists to predict and prevent the development of antibiotic resistance during treatments."

The study published in Nature Communications is entitled, "A non-canonical mismatch repair pathway in prokaryotes".

Explore further: Research sheds light on mechanism that leads to drug-resistant superbugs

Related Stories

Research sheds light on mechanism that leads to drug-resistant superbugs

September 29, 2016
Drug-resistant organisms, or so-called "superbugs," are a growing public health threat because "last-resort" therapeutics-employed only when other drugs fail to kill an infection-are failing. A University of Georgia-led research ...

Drug resistance mutations also enhance growth in malaria parasite

November 10, 2016
Some mutations that enable drug resistance in the malaria-causing parasite Plasmodium falciparum may also help it grow, according to a new study published in PLOS Pathogens.

'Lonely' bacteria increase risk of antibiotic resistance

April 29, 2014
Scientists from The University of Manchester have discovered that 'lonely' microbes are more likely to mutate, resulting in higher rates of antibiotic resistance.

Scientists reveal how natural antibiotic kills tuberculosis bacterium

September 17, 2012
A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown ...

Recommended for you

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

katesisco
1 / 5 (1) Jan 28, 2017
Could this be behind the reason leprosy now infects an estimated 5% with non mutated leprosy? And the reason HIV resistance exists in leprosy infected Europe?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.